Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Flora Transplantation for Recurrent Bacterial Vaginosis
NCT02236429Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Jun 2015
- Primary completion
- Mar 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label, single-arm trial of vaginal flora transplant in bacterial vaginosis (BV), sponsored by Hadassah Medical Organization. Primary endpoint: Relief of bacterial vaginosis at 12 months. Started Jun 2015; status: completed.
02
Drugs
vaginal flora transplant
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02236429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236429.